Clinical Trials Browser

Phase 2 × Cyclooxygenase 2 Inhibitors × Gastrointestinal × Clear all

NCT00198081 2016-02-29

Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)

Phase 2 Terminated

8 enrolled 11 charts

Gastrointestinal

Pancreatic Neoplasms